Evidence map›Paper›PMID 38413718›Full record

ArticleLeukemia2024

Germline variants in patients developing second malignant neoplasms after therapy for pediatric acute lymphoblastic leukemia-a case-control study.

Stefanie V Junk, Alisa Förster, Gunnar Schmidt, Martin Zimmermann, Birthe Fedders, Bernd Haermeyer, Anke K Bergmann, Anja Möricke, Gunnar Cario, Bernd Auber and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Frontiers in oncology · 2026
    Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Stefanie V JunkPediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany. stefanie.junk@med.uni-duesseldorf.de.ORCID 0000-0001-8206-9463
Alisa FörsterInstitute of Human Genetics, Hannover Medical School, Hannover, Germany.
Gunnar SchmidtInstitute of Human Genetics, Hannover Medical School, Hannover, Germany.
Martin ZimmermannPediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-0365-3512
Birthe FeddersDepartment of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.
Bernd HaermeyerInstitute of Human Genetics, Hannover Medical School, Hannover, Germany.
Anke K BergmannInstitute of Human Genetics, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-1367-2725
Anja MörickeDepartment of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.
Gunnar CarioDepartment of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.
Bernd AuberInstitute of Human Genetics, Hannover Medical School, Hannover, Germany.
Martin SchrappeDepartment of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.ORCID 0000-0003-0034-5845
Christian P KratzPediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.ORCID 0000-0003-4120-5873
Martin StanullaPediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany. stanulla.martin@mh-hannover.de.ORCID 0000-0002-3834-0727

Funding

Wilhelm Sander-Stiftung (Wilhelm Sander Foundation) 2020.098.1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neoplasms, Second PrimaryPrecursor Cell Lymphoblastic Leukemia-LymphomaCase-Control StudiesChildGerm CellsGerm-Line MutationHumans

Identifiers

PMID38413718
PMCPMC10997515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.